Stockscreener 앱 받기
6.46
4.01%
-0.27
시간 외 거래:
6.46
전일 마감가:
$6.73
열려 있는:
$6.65
하루 거래량:
43,010
Relative Volume:
0.25
시가총액:
$6.45M
수익:
$12.99M
순이익/손실:
$-23.72M
주가수익비율:
-0.0664
EPS:
-97.2514
순현금흐름:
$-23.28M
1주 성능:
-12.11%
1개월 성능:
+7.49%
6개월 성능:
-77.71%
1년 성능:
-99.35%
1일 변동 폭
$6.46
$6.77
1주일 범위
$6.45
$7.415
52주 변동 폭
$5.94
$1,299.60
Aptevo Therapeutics Inc Stock (APVO) Company Profile
명칭
Aptevo Therapeutics Inc
전화
206-838-0500
주소
2401 4TH AVE., SEATTLE, WA
Compare APVO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
6.46 | 6.72M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-11-05 | 개시 | Ladenburg Thalmann | Buy |
| 2017-10-05 | 재개 | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
10 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
APVO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aptevo Therapeutics (NASDAQ:APVO) Upgraded at Wall Street Zen - Defense World
Retail Surge: Can Moodys Corporation reach resistance levels soon2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
APVO SEC FilingsAptevo Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aptevo Therapeutics Inc expected to post a loss of $8.10 a shareEarnings Preview - TradingView
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Institution Moves: How volatile is FATBW stockJuly 2025 Drop Watch & Expert Curated Trade Ideas - baoquankhu1.vn
Aptevo Therapeutics (APVO) sees Point72 report 0% ownership - Stock Titan
Seattle biotech CEO to step down, replacement named - The Business Journals
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Intellectia AI
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Drop in Short Interest - Defense World
Will Aptevo Therapeutics Inc. stock remain a Wall Street favorite2025 Performance Recap & Long-Term Investment Growth Plans - mfd.ru
Will Aptevo Therapeutics Inc. be affected by tariffsCPI Data & AI Based Buy and Sell Signals - mfd.ru
Can Aptevo Therapeutics Inc. navigate macro headwindsJuly 2025 News Drivers & Technical Buy Zone Confirmation - mfd.ru
What is Aptevo Therapeutics Inc.’s valuation compared to sectorM&A Rumor & Accurate Entry/Exit Alerts - mfd.ru
Why Aptevo Therapeutics Inc. stock attracts high net worth investorsProduct Launch & Real-Time Market Sentiment Alerts - mfd.ru
Is Aptevo Therapeutics Inc. stock a value trapQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - mfd.ru
Aug Rallies: What is Aptevo Therapeutics Inc. s 5 year growth outlookJuly 2025 Setups & Verified Entry Point Detection - mfd.ru
Risk Report: Is Aptevo Therapeutics Inc impacted by rising ratesChart Signals & Safe Swing Trade Setups - baoquankhu1.vn
Is Aptevo Therapeutics Inc. stock a top momentum playSell Signal & Reliable Entry Point Alerts - mfd.ru
Aptevo Therapeutics Announces CEO Transition and Leadership Changes - The Globe and Mail
Aptevo Therapeutics announces leadership changes as CEO retires By Investing.com - Investing.com Canada
Aptevo Announces CEO Changes - marketscreener.com
Aptevo Therapeutics Inc. Announces Board and Executive Changes - marketscreener.com
Aptevo Therapeutics Names Jeff Lamothe President and CEO as Marvin White Becomes Executive Chair - citybiz
Is Onto Innovation Inc stock risky to hold now2025 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
Aptevo Therapeutics (APVO) Announces Changes in Leadership to Pr - GuruFocus
Aptevo Therapeutics IncMarvin White to retire as Aptevo CEO effective April 1, 2026SEC filing - marketscreener.com
Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth - The Globe and Mail
Aptevo Therapeutics announces leadership changes as CEO retires - Investing.com
Aptevo (NASDAQ: APVO) elevates COO Jeff Lamothe to succeed CEO Marvin White - Stock Titan
Cancer drug developer Aptevo hands CEO role to operations chief - Stock Titan
Aptevo Therapeutics (APVO) Announces Offering of 7.075 Million S - GuruFocus
Aptevo Therapeutics prospectus relates to offer and sale of up to 7,075,471 shares of our common stock by selling stockholder - marketscreener.com
Aptevo Therapeutics Prospectus Relates To Offer And Sale Of Up To 7,075,471 Shares Of Our Common Stock By Selling Stockholder - TradingView
Aug Rallies: Is Aptevo Therapeutics Inc impacted by rising ratesJuly 2025 EndofMonth & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Growth Report: Can Compass Minerals International Inc. deliver consistent EPS growthInsider Selling & Community Verified Swing Trade Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Take Profit: Is Weave Communications Inc a defensive stock2025 Analyst Calls & Accurate Intraday Trading Signals - baoquankhu1.vn
VIX Spike: What are Aptevo Therapeutics Incs recent SEC filings showingTrade Exit Report & Fast Moving Market Watchlists - baoquankhu1.vn
Chipmakers Recap: Is NTNX stock overvalued or fairly priced2025 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
Aptevo Therapeutics (NASDAQ: APVO) seeks OK for $60M SEPA share sales - Stock Titan
Income Plays: Does Eastman Kodak Company align with a passive investing strategy - baoquankhu1.vn
Market Overview: How sensitive is HUHUTECH International Group Inc to inflationJuly 2025 Movers & Verified Momentum Stock Watchlist - baoquankhu1.vn
Aptevo Therapeutics (APVO) Price Target Increased by 1,700.00% to 7,711.20 - Nasdaq
Aptevo Therapeutics shares jump after $60 million equity facility secured - MSN
HOKA Size Guide: What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - Улправда
Aptevo Therapeutics Secures $60 Million Equity Financing Facility - The Globe and Mail
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aptevo Therapeutics Inc (APVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):